Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. Vascular Access devices for Hemodialysis include AV Fistula Needles, Grafts, Vascular Covered Stents, and Hemodialysis Catheters. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular access devices for hemodialysis devices market, including market shares of different players within Italy. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the vascular access devices for hemodialysis market in Italy was Fresenius SE & Co followed by Baxter International, Becton Dickinson and Co, Medtronic, B. Braun Melsungen, W. L. Gore & Associates and Nipro.
Fistula needles are used to surgically create a direct connection between an artery and a vein resulting in the formation of a large blood vessel with an increased blood flow, providing access for hemodialysis. Grafts are strong artificial tubes inserted by surgeons underneath the skin of the patient’s forearms, upper arms or thigh. Vascular Covered Stent is an expandable, flexible, metal (nitinol) tube-shaped device (stent) that is covered with a material called expanded polytetrafluoroethylene (ePTFE). Hemodialysis catheters are intended for exchanging blood from the patient to and from the hemodialysis machine.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the vascular access devices for hemodialysis devices market within Italy was expected to be over $10m in 2022.
For the latest complete market share analysis of vascular access devices for hemodialysis device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
